Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB25FQRNZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,097
Award facts
- Contract value 100% obligated
- $17,097.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,097.24 by the Defense Logistics Agency on August 20, 2025, for the supply of SKYRIZI 150 MG/ML per milliliter. This is a firm fixed price contract with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for ultimate completion by August 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken facility. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. DLA, which operates under the Department of Defense, utilizes such prime vendor contracts to efficiently distribute critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive pharmaceutical portfolio and logistics infrastructure, positions it as a key vendor within the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQRNZ?
SPE2DB25FQRNZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FQRNZ worth?
The government has obligated $17,097 on SPE2DB25FQRNZ.
Is contract SPE2DB25FQRNZ an order under another contract?
Yes. SPE2DB25FQRNZ is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQRNZ competed?
The extent of competition for SPE2DB25FQRNZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award